Studies were performed to explore the effect on normal lymphocyte function of serum derived from patients with alcohol-induced liver injury and healthy controls. We examined the effect of such serum on the generation of both spontaneous and Concanavalin A (Con A)-induced lymphocyte cytotoxicity for Chang target cells. Normal lymphocytes, when incubated in the presence of 5% serum from patients with alcoholic liver disease, showed a marked (20.75 i 5.1% mean i SEM) reduction in the capacity to generate spontaneously cytotoxic cells compared to 5% control serum (3.2 i 1.91%) (p < 0.001). Similar results were found in studies of Con A-stimulated cytotoxicity (36 ± 7.2% vs. 5 * 2.3%; p < 0.001). Fractionation of serum by gel chromatography demonstrated the presence of inhibitory activity of various molecular weights, although a major peak of inhibitory activity (approximately 270,000 daltons) was identified in severe alcoholic hepatitis. Thus, this study demonstrates the presence of serum inhibitors in alcoholic liver disease which influence normal lymphocyte function.
INTRODUCTION
Alcoholic liver disease and, in particular, acute alcoholic hepatitis have been associated with a number of immunologic abnormalities. In vivo studies of delayed hypersensitivity skin testing have shown depressed thymus-derived or T-lymphocyte function in patients with alcohol-induced liver injury [1, 2] . In such patients, both a peripheral T-lymphopenia and marked accumulation of T-cells at the site of liver injury have been described [3, 4] and in vitro studies of lymphocyte activity have demonstrated depressed lymphocyte responsiveness to antigens and mitogens [5] . Furthermore, lymphocyte reactivity to liver tissue antigens and alcoholic hyalin have been demonstrated in some individuals [5] [6] [7] . More important, mononuclear cells from patients with alcoholic hepatitis but not inactive Laennec's cirrhosis exhibit cytotoxicity to autologous and heterologous cell lines, suggesting prior in vivo lymphocyte activation [8] [9] [10] . It is uncertain, however, whether these immunologic abnormalities are primary and of pathogenetic significance or represent secondary and non-specific changes due to the disease process or a direct alcohol effect on immunologic responsiveness.
The importance of external modulating factors on in vitro lymphocyte function has only recently been appreciated. In patients with alcoholic liver disease, serum factors have been shown to play an important role in certain aspects of cell function.
For example, DeMeo and Andersen [I1] studied neutrophil chemotaxis in patients with alcoholic liver disease and found that the cirrhotic patients had marked impairment of chemotaxis compared to normal controls when neutrophils were incubated with autologous but not homologous normal serum. Of particular interest were investigations in which normal leukocytes exhibited defective chemotaxis in the presence of alcoholic liver disease serum but not in the presence of normal serum. Thus, this study represents an example of an external modulating serum factor(s) on a particular cell function in patients with alcohol-induced liver injury.
In the present investigation, we examined the effect of serum obtained from patients in various stages of acute alcoholic liver injury on the generation of cytotoxic lymphocytes. Our results indicated that there are potent serum inhibitors which depress the generation of cytotoxic lymphocytes derived from normal individuals.
MATERIALS AND METHODS

Patients
Fifteen patients with alcohol-related liver disease were investigated. Twelve of the 15 underwent liver biopsy; 7 demonstrated morphologic features consistent with alcoholic hepatitis [12] , 4 with Laennec's cirrhosis, and 1 with fatty liver. Ten milliliters of venous blood was collected from each patient and the separated serum stored at -70°C for subsequent studies. All patients were hospitalized and studied between 3 days and 2 weeks following admission. This protocol has been approved by the Human Studies Committee at the Massachusetts General Hospital.
Preparation of Lymphocytes
Mononuclear cells obtained from normal individuals were prepared from 40 to 50 ml of fresh heparinized venous blood by dilution with an equal volume of isotonic saline and centrifugation through a Ficoll/ Hypaque sedimentation gradient 400 x g for 35 min; the mononuclear cell band at the saline-Ficoll/Hypaque interface was removed. Cells were washed three times (400 x g for 10 min) in RPMI 1640 medium (Microbiological Associates, Bethesda, MD) enriched with 10% heat-inactivated fetal calf serum, 20 mM glutamine, penicillin (1000 units/ml) and streptomycin (100 ,ug/ ml) (complete medium). Cells were resuspended in complete medium and adjusted to a concentration of 1 x 106 cells/ ml. Under these conditions cell viability was > 95% by trypan blue exclusion.
Preparation of Target Cells
Chang cells (Microbiological Associates) were continuously cultivated in our laboratory and a single cell suspension was harvested by brief treatment with trypsin (5 min). Cells were washed three times in RPMI medium, resuspended in 5 ml of complete medium, and incubated with 300 /ACi of 51Cr (New England Nuclear, Boston, MA) for 30 min at 37°C. Radiolabeled Chang cells were washed X3 with 10 ml of complete medium, counted, and rechecked for viability with trypan blue. The 
Cytotoxicity Studies
In both the spontaneous and Con A-induced lymphocyte cytotoxicity studies, done in triplicate, 2 ml of complete medium containing 1 x 106 mononuclear cells/ ml were added to 1 x 104 labeled Chang cells in 1 ml of complete medium to yield a lymphocyte to target cell ratio of 200:1. In spontaneous lymphocyte cytotoxicity studies 2 x 106 lymphocytes were incubated in complete RPMI medium for 18 hours with 1 x 104 Chang cells on a rocker platform (6 cycles/min at 37°C in a 95% air and 5% CO2 atmosphere). At cells/ ml in complete medium (total volume 2 ml) with 10 Mg/ ml Con A for 72 hr in a 5% Co2 incubator at 370 C. At the end of this incubation period, cell suspensions were added to 1 x 104 51Cr-Chang cells and incubated for 6 hr as described above and the percent cytotoxicity determined.
Inhibition of Lymphocyte Cytotoxicity by Serum
Serum from patients with alcohol-related liver injury and from normal control individuals was heat-inactivated at 560C for 30 min. Such serum at a concentration of 5% was added to duplicate cultures at the beginning of the 18 Fig. 1 , there was a substantial difference in the inhibition of spontaneous cytotoxic lymphocytes when cells were incubated in the presence of 5% normal serum compared to 5% alcoholic liver disease serum (3.2 ± 1.9 vs. 20.75 ± 5.1%; p < 0.001). Similarly, in Con A-stimulated experiments in which maximum cytotoxicity is generated, alcoholic liver disease serum inhibited cytotoxicity by 36 ± 7.2% as compared to 5 ± 2.3% inhibition by normal serum (p < 0.001).
We compared the results obtained on serum inhibition of cytotoxicity exhibited in Table 1 . (Clinical and laboratory features of these patients are presented for reference in Table 2 .) There was no relationship between the magnitude of depressed lymphocyte reactivity in the two assays. In fact, we observed in some patients a dissociation between the inhibitory effect of serum in the spontaneous assay compared to the Con A-stimulated studies (e.g., Patients 1 and 5). However, the greatest degree of serum inhibitory activity was observed in patients with severe alcoholic hepatitis. Partial Characterization of Serum Inhibitors Figure 3 depicts a representative elution profile of serum inhibitory activity on Sephadex G-200 columns in two patients with severe alcoholic hepatitis (III and IV) compared to a patient with active Laennec's cirrhosis (II) and a normal control (I). All three patients had previously deternrined inhibitory activity when tested at a 5% serum concentration in the Con A-stimulated cytotoxicity assay. In the alcoholic VOLlUME (m/l hepatitis patients there was a peak of serum inhibitory activity corresponding to a molecular weight of approximately 270,000 daltons when further analyzed by Sepharose 4B chromatography (data not shown). However, lower levels of inhibitory activity were observed in lower molecular weight fractions on Sephadex G200 as exemplified by patient II with active Laennec's cirrhosis. DISCUSSION
In patients with alcohol-related liver injury we demonstrated the existence of serum factor(s) which inhibit the generation of cytotoxic activity in lymphocytes obtained from normal controls. What are the biological properties and significance of these inhibitory substances? In the first place, the biological potency varies from patient to patient as shown in some studies (Fig. 3, patient III Recent studies have demonstrated that Con A-stimulated lymphocyte cytotoxicity toward Chang cells is probably mediated by T-lymphocytes whereas spontaneous cytotoxicity directed against these same target cells is a property of a non-adherent, surface immunoglobulin-negative, Fc receptor-positive cell population [13] [14] . Based on the dissociation noted in many patients between the degree of inhibition in the spontaneous and the Con A-induced cytotoxicity experiments, we are tempted to speculate that these serum inhibitors may influence lymphocyte subpopulations to variable degrees; however, lymphocyte separation experiments are necessary to explore this possibility.
In this study we chose to focus on the effects of serum inhibitory factors on normal lymphocyte reactivity, for patients with liver disease may have intrinsic as well as extrinsic defects in lymphocyte function. Indeed, three types of serum inhibitors (extrinsic factors) which influence various aspects of lymphocyte reactivity have been described. Several studies have shown that in pwtients with a variety of liver diseases (alcoholic hepatitis, viral hepatitis, primary biliary cirrhosis, halothane hepatitis, and extrahepatic biliary obstruction) there are serum inhibitors which depress phytohemagglutinin (PHA) stimulated blast transformation in lymphocytes obtained both from patients and normal individuals [15] [16] [17] [18] [19] [20] . The properties of these inhibitors are unknown.
More recently, Chisari et al. have described a "regulatory" low density lipoprotein which inhibits T-lymphocyte binding to sheep red blood cells (SRBC rosette formation) in patients with acute viral hepatitis. This substance has been named rosette inhibitory factor or RIF [21, 22] . Rosette inhibitory factor is biologically active at extremely low concentrations and is found in approximately 50 percent of patients with type A or B hepatitis during the active course of illness. Apparently RIF has unusual specificity for viral hepatitis and has not been detected in other viral diseases or in a variety of acute and chronic liver diseases of other etiologies. More important, the persistence of this factor in the blood following acute hepatitis has been associated with unresolved hepatitis and chronic active hepatitis. No correlation has been found, however, between RIF and the inhibitory factor(s), mentioned above, which inhibit the DNA synthetic response to PHA [22] .
A third serum factor has been described in patients with acute and chronic active hepatitis which inhibits spontaneous and Con A-induced lymphocyte cytotoxicity [23] . These factor(s), like RIF, disappear with clinical recovery [24] ; however, the biological properties differ from those of RIF in that the major peak of serum inhibitory activity determined by gel chromatography occurs in the 160,000-180,000 dalton range in contrast to the large molecular weight of RIF [22] . The above data suggest that there are multiple serum inhibitors of lymphocyte function in patients with acute and chronic active hepatitis, some of which may be more specific for the disease process than others.
We have shown, in addition, that in patients with alcoholic liver disease serum inhibitors occur which influence the generation of cytotoxic lymphocytes. These inhibitors were partially characterized and found to differ in molecular weight from 622 WANDS AND DIENSTAG LYMPHOCYTE INHIBITION IN ALCOHOLIC LIVER DISEASE 623 those previously described in acute and chronic active hepatitis and primary biliary cirrhosis [25] . Similar to the inhibitors observed by DeMeo et al. [11] , the serum factor(s) described here exert an inhibitory effect on normal cells. Finally, additional studies are required to define further the physical properties of these inhibitors, examine inhibitory effects of serum on lymphocyte subpopulations and other forms of lymphocyte reactivity, determine whether the activity of these inhibitors varies during the natural course of alcohol-induced liver injury, and explore the biological significance of these potential regulatory substances.
